2019 Autumn Conference Posters

Click title to view pdf. Posters are listed in alpha order by first author.

Using smartphones to measure symptoms of schizophrenia in patients enrolled in a clinical trial (Abstract)

Abbas

Computational optimization and participatory design of a novel spatial working memory task for autism trials (Abstract)

Chatham

Early errors in ePRO completion predict future errors an opportunity for intervention (Abstract)

Daniel

Critical evaluation of Vineland-II and Vineland-3 as outcome measures for autism clinical trials (Abstract)

Dawson

New paediatric cognitive assessment methods for epilepsy trials in developing countries (Abstract)

Di Cesare

Variability in rates of rating errors in the PANSS across different countries (Abstract)

Echevarria

IRT person ability scores as an alternative to norm-referenced scores in neurodevelopmental trials (Abstract)

Farmer

Impact of cognitive heterogeneity on signal detection in trial of cognitive impairment in schizophrenia (Abstract)

Goldman

Sleep analysis with Somno-Art compared to full PSG in apneic patients and healthy controls (Abstract)

Gruber

Utility of double-blind crossover protocol for photosensitivity model assessment of PF-06372865 (Abstract)

Gurrell

Evaluating severity of depressive symptoms using upper body motion and machine learning (Abstract)

Horigome

Training improves patient understanding of complex PRO terminology nausea and vomiting (Abstract)

Howley

Integrating ePROs in schizophrenia trials clinician and patient perceptions for scale refinement (Abstract)

Khan

Accuracy in identifying and describing seizures among trial subjects with and without epilepsy (Abstract)

Khurana

Third generation of negative symptom assessment validation of digital phenotyping in schizophrenia (Abstract)

Kirkpatrick

Linking the PSP and CGI in subjects with predominant negative symptoms (Abstract)

Kott

Qual-ABC reviewer scores as indicator of screen failure and early termination (Abstract)

Liu

Signal detection in schizophrenia trials contribution of responders versus partial non-responders (Abstract)

Loebel

Beyond the C-SSRS incorporating direct patient reports of suicidality into safety monitoring (Abstract)

McNamara

Improving data quality and administration of CDR system in clinical trials (Abstract)

Micaletto

Methodological insights from exploratory pharmacokinetic pharmacodynamic study of scopolamine and donepezil (Abstract)

Mohse

Driving paradigm optimization for clinical trials RTOC consortium and validation of reward processing tasks (Abstract)

Pollentier

Utilizing smartphones to assess depression insights from fully remote randomized clinical trials (Abstract)

Pratap

REIMAGINE CNS basket trial exploring vafidemstat for aggression in psychiatric disorders (Abstract)

Ropacki

Impact of data quality program on NPI-C scale in agitation in dementia trials (Abstract)

Roy

Benefits of standard of care treatment study to prepare participants for TRD trial (Abstract)

Sauder

Treasure Hunt game-theoretic approach to detecting changes in Theory of Mind (Abstract)

Simillion

Use of a voice-based digital biomarker in patients with depression (Abstract)

Simpson

Central rating review reduces error rates and improves data quality in prodromal Alzheimer disease trial (Abstract)

Smigorski

Concordance analyses of paired PANSS surveillance ratings in schizophrenia study (Abstract)

Targum

Explainable AI to differentiate drug and placebo responders for enhanced patient selection (Abstract)

Tiller

Characteristics of the CADSS in assessment of dissociation after first esketamine administration (Abstract)

Yavorsky